Midwest Trust’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Midwest Trust's DGX Position: Q3 2026 in Review
Midwest Trust reduced its Quest Diagnostics (DGX) stake by 1.9% in Q3 2026, selling an estimated $427K and leaving 93,049 shares worth $21.7M. The position accounts for 0.24% of the portfolio, ranked #98.
Midwest Trust first reported a position in DGX in Q2 2025 and has held it in 6 quarters since. 236 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Midwest Trust held 93,049 shares of Quest Diagnostics worth $21.7M as of Q3 2026.
- Midwest Trust sold 1,847 Quest Diagnostics shares in Q3 2026, an estimated $427K.
- Quest Diagnostics made up 0.24% of Midwest Trust's portfolio in Q3 2026, its #98 holding.
- Midwest Trust first reported a position in Quest Diagnostics in Q2 2025 and has held it in 6 quarters since.
- 236 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Midwest Trust's 13F filing for Q3 2026, filed 22 Oct 2026.